Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdou Beziane"'
Autor:
Daniel Bertin, Alexandre Brodovitch, Alexandre Lopez, Robin Arcani, Grace M. Thomas, Abdou Beziane, Samuel Weber, Benjamin Babacci, Xavier Heim, Louise Rey, Marc Leone, Jean Louis Mege, Nathalie Bardin
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Whereas the detection of antiphospholipid autoantibodies (aPL) in COVID-19 is of increasing interest, their role is still unclear. We analyzed a large aPL panel in 157 patients with COVID-19 according to the disease severity. We also investi
Externí odkaz:
https://doaj.org/article/a18c661d3a3a4ed49509c6f5622af0a9
Autor:
Nathalie Bardin, Abdou Beziane, Alexandre Brodovitch, J.L. Mège, Daniel Bertin, Sylvia Hug, Xavier Heim, Afaf Bouamri
Publikováno v:
Arthritis & rheumatology
Arthritis & rheumatology, Wiley, 2020, 72 (11), pp.1953-1955. ⟨10.1002/art.41409⟩
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & Rheumatology
Arthritis & rheumatology, 2020, 72 (11), pp.1953-1955. ⟨10.1002/art.41409⟩
Arthritis & rheumatology, Wiley, 2020, 72 (11), pp.1953-1955. ⟨10.1002/art.41409⟩
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & Rheumatology
Arthritis & rheumatology, 2020, 72 (11), pp.1953-1955. ⟨10.1002/art.41409⟩
A growing body of evidence indicates that patients with cardiovascular complications are at a higher risk for developing severe Coronavirus Disease 2019 (COVID‐19) (1). In addition, the high incidence of thromboembolic events suggests an important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bbcd0a3de611d273ec3c2fc39675a6
https://hal-amu.archives-ouvertes.fr/hal-03159326
https://hal-amu.archives-ouvertes.fr/hal-03159326
Autor:
Laura Despierres, Gilles Kaplanski, William Cohen, Pierre-Emmanuel Morange, Pascal Rossi, Florence Bretelle, Brigitte Granel, Jacques Serratrice, Pierre Bongrand, Jean Robert Harlé, Abdou Beziane, Pierre Jean Weiller, Nathalie Bardin
Publikováno v:
Rheumatology (Oxford, England). 53(7)
Objectives. Although the last international guidelines for aPL recommended determination of IgA aCL and anti-b2glycoprotein I (ab2GPI) antibodies for the evaluation of APS in the absence of conventional IgG or IgM aCL and ab2GPI antibodies, the clini